These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32667880)

  • 21. Impact of systemic lupus erythematosus on burden of illness and work productivity in the United States.
    Garris C; Oglesby A; Sulcs E; Lee M
    Lupus; 2013 Sep; 22(10):1077-86. PubMed ID: 23920376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.
    Khamashta MA; Bruce IN; Gordon C; Isenberg DA; Ateka-Barrutia O; Gayed M; Donatti C; Guillermin AL; Foo J; Perna A
    Lupus; 2014 Mar; 23(3):273-83. PubMed ID: 24356612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The economic burden of systemic lupus erythematosus in Asia: the current state.
    Mak A
    Lupus; 2010 Oct; 19(12):1442-6. PubMed ID: 20947555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Men Who Have Sex With Men-Friendly Doctor Finder Hackathon in Guangzhou, China: Development of a Mobile Health Intervention to Enhance Health Care Utilization.
    Li C; Xiong Y; Sit HF; Tang W; Hall BJ; Muessig KE; Wei C; Bao H; Wei S; Zhang D; Mi G; Yu F; Tucker JD
    JMIR Mhealth Uhealth; 2020 Feb; 8(2):e16030. PubMed ID: 32130189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and cost-effectiveness of a multicomponent intervention to implement a clinical practice guideline for systemic lupus erythematosus: protocol for a cluster-randomized controlled trial.
    Trujillo-Martín MM; Ramallo-Fariña Y; Del Pino-Sedeño T; Rúa-Figueroa Í; Trujillo-Martín E; Vallejo-Torres L; Imaz-Iglesia I; Sánchez-de-Madariaga R; de Pascual-Medina AM; Serrano-Aguilar P;
    BMC Health Serv Res; 2019 Nov; 19(1):783. PubMed ID: 31675957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Socioeconomic status at diagnosis influences the incremental direct medical costs of systemic lupus erythematosus: A longitudinal population-based study.
    McCormick N; Marra CA; Sadatsafavi M; Aviña-Zubieta JA
    Semin Arthritis Rheum; 2020 Feb; 50(1):77-83. PubMed ID: 31358362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs.
    Clarke AE; Esdaile JM; Bloch DA; Lacaille D; Danoff DS; Fries JF
    Arthritis Rheum; 1993 Nov; 36(11):1548-59. PubMed ID: 8240431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total cost and cost predictors in systemic lupus erythematosus - 8-years follow-up of a Swedish inception cohort.
    Jönsen A; Bengtsson AA; Hjalte F; Petersson IF; Willim M; Nived O
    Lupus; 2015 Oct; 24(12):1248-56. PubMed ID: 25957301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study.
    Miyazaki C; Sruamsiri R; Mahlich J; Jung W
    J Med Econ; 2020 Jul; 23(7):786-799. PubMed ID: 32149541
    [No Abstract]   [Full Text] [Related]  

  • 30. The patient's perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus?
    Kernder A; Elefante E; Chehab G; Tani C; Mosca M; Schneider M
    Rheumatology (Oxford); 2020 Dec; 59(Suppl5):v63-v68. PubMed ID: 33280017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis.
    Aghdassi E; Zhang W; St-Pierre Y; Clarke AE; Morrison S; Peeva V; Landolt-Marticorena C; Su J; Reich H; Scholey J; Herzenberg A; Pope JE; Peschken C; ; Wither JE; Fortin PR
    J Rheumatol; 2011 Apr; 38(4):658-66. PubMed ID: 21159829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychological Implications to the Therapy of Systemic Lupus Erythematosus.
    Warchoł-Biedermann K; Mojs E; Sikorska D; Kotyla P; Teusz G; Samborski W
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36498095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse pregnancy outcomes in adolescents and young women with systemic lupus erythematosus: a national estimate.
    Ling N; Lawson E; von Scheven E
    Pediatr Rheumatol Online J; 2018 Apr; 16(1):26. PubMed ID: 29661199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
    Oglesby A; Korves C; Laliberté F; Dennis G; Rao S; Suthoff ED; Wei R; Duh MS
    Appl Health Econ Health Policy; 2014 Apr; 12(2):179-90. PubMed ID: 24573911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China.
    Zhang L; Geng S; Qian L; Ye S; Wang X; Lu G; Ding Y; Li T
    Int J Clin Pharm; 2019 Oct; 41(5):1247-1255. PubMed ID: 31240553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada.
    Fatoye F; Gebrye T; Svenson LW
    PLoS One; 2021; 16(5):e0251409. PubMed ID: 33961687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-of-illness studies in systemic lupus erythematosus: A systematic review.
    Zhu TY; Tam LS; Li EK
    Arthritis Care Res (Hoboken); 2011 May; 63(5):751-60. PubMed ID: 21557530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poverty, Neighborhoods, Persistent Stress, and Systemic Lupus Erythematosus Outcomes: A Qualitative Study of the Patients' Perspective.
    Yelin E; Trupin L; Bunde J; Yazdany J
    Arthritis Care Res (Hoboken); 2019 Mar; 71(3):398-405. PubMed ID: 29781579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep quality, clinical and psychological manifestations in women with systemic lupus erythematosus.
    Moraleda V; Prados G; Martínez MP; Sánchez AI; Sabio JM; Miró E
    Int J Rheum Dis; 2017 Oct; 20(10):1541-1550. PubMed ID: 28425178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids.
    Ng X; dosReis S; Beardsley R; Magder L; Mullins CD; Petri M
    Lupus; 2018 Mar; 27(3):475-483. PubMed ID: 28857718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.